HIMS250110P26000
- 0.65
- 0.000.00%
Hims & Hers Health Newsroom
Analysts Conflicted on These Healthcare Names: Atricure (ATRC) and Hims & Hers Health (HIMS)
Hims & Hers Health Options Spot-On: On January 21st, 84,027 Contracts Were Traded, With 461.96K Open Interest
Unusual Options Activity: TECK, HIMS and Others Attract Market Bets, TECK V/OI Ratio Reaches 86.5
Insider Sale: Chief Executive Officer of $HIMS (HIMS) Sells 40,553 Shares
Hims & Hers Health Unusual Options Activity
8 Health Care Stocks Whale Activity In Today's Session
Hims & Hers Health Options Spot-On: On January 17th, 102.64K Contracts Were Traded, With 520.85K Open Interest
Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today
Hims & Hers Health Down 3% After BoA Says Q4 Revenue Could Be a Miss
BofA Securities Maintains Hims & Hers Health(HIMS.US) With Sell Rating, Maintains Target Price $18
Cautious Outlook on Hims & Hers Health Amid Regulatory Risks and Revenue Concerns
Express News | U.S. FDA Chief Califf Says Current Regulations Not Enough To Protect Americans From Risks Of Compounded GLP-1 Drugs
Investors in Hims & Hers Health (NYSE:HIMS) Have Seen Enviable Returns of 440% Over the Past Three Years
10 Health Care Stocks With Whale Alerts In Today's Session
Hims & Hers in Focus as Eli Lilly GLP-1 Sales Disappoint
Needham's Top Stocks for 2025: AX, CYBR, CART and More
Morgan Stanley Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Maintains Target Price $42
Hims & Hers Health: Strong App Download Momentum and New Product Launches Drive Buy Recommendation
Hims & Hers Health Shares Fall After Downgrade From Citigroup
Express News | Watching Hims & Hers Health; Traders Circulate Popular Retail Trading Newsletter Saying Stock Is Poised For A Major Surge In 2025